Antithrombotic therapy in valvular heart disease.
Salem
D N
DN
New England Medical Center, Boston, MA 02111-1526, USA.
Levine
H J
HJ
Pauker
S G
SG
Eckman
M H
MH
Daudelin
D H
DH
D002114:Calcinosis / Q000150:complications; D004696:Endocarditis / Q000150:complications; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006344:Heart Septal Defects, Atrial / Q000150:complications; D006349:Heart Valve Diseases / Q000150:complications*; D006801:Humans; D008945:Mitral Valve Prolapse / Q000150:complications; D012214:Rheumatic Heart Disease / Q000150:complications; D013923:Thromboembolism / Q000209:etiology / Q000517:prevention & control*; D014859:Warfarin / Q000627:therapeutic use
D005343:Fibrinolytic Agents; D014859:Warfarin